Wayne’s Teleflex, the medical-device company that recently acquired the maker of the UroLift urinary-tract implant, is one of an exclusive group of companies that saw its stock soar in 2017, writes Joseph DiStefano for the Philadelphia Inquirer.

Teleflex is one of the companies taking advantage of advances in medical and communications technology to achieve higher profits and deliver higher returns. It saw its stock increase by more than 50 percent, proving that the addition of the implant for patients with enlarged prostates was the right decision for its shareholders.

However, while the stock grew steadily throughout most of the year, it did slip a little in December while the broader index continued to rise. But this did not worry local analysts, who remain bullish.

Dan Wantrobski, research head at Janney Montgomery Scott, believes that the around 90 million millennials who are currently getting integrated into the workforce will be the driving force for the market.

“They will be consumers, investors, savers,” he said. “A new generation looking for work, building houses, trying to buy cars. Disruptive. Very bullish. Stocks tend to thrive off that.”

Read more about the rising stock in the Philadelphia Inquirer here, and check out previous VISTA Today coverage of Teleflex here.